Wang, X. et al. The prospective value of dopamine receptors on bio-behavior of tumor. J. Cancer 10, 1622 (2019).
Google Scholar
Noble, E. P. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1, 309–333 (2000).
Google Scholar
Grossrubatscher, E. et al. High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors. Cancer Biol. Ther. 7, 1970–1978 (2008).
Google Scholar
Sachlos, E. et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 149, 1284–1297 (2012).
Google Scholar
Shin, J. H. et al. Sertindole, a potent antagonist at dopamine D2 receptors, induces autophagy by increasing reactive oxygen species in SH-SY5Y neuroblastoma cells. Biol. Pharm. Bull. 35, 1069–1075 (2012).
Google Scholar
Yang, Y. et al. Repositioning dopamine D2 receptor agonist bromocriptine to enhance docetaxel chemotherapy and treat bone metastatic prostate cancer. Mol. Cancer Ther. 17, 1859–1870 (2018).
Google Scholar
Qun, H. & Yuan, L.-B. Dopamine inhibits proliferation, induces differentiation and apoptosis of K562 leukaemia cells. Chin. Med. J. 120, 970–974 (2007).
Ganguly, S. et al. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation. Am. J. Pathol. 177, 2701–2707 (2010).
Google Scholar
De Leeuw Van Weenen, J. et al. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem. Pharmacol. 20, 1827–1836 (2010).
Liu, X. et al. The mechanism and pathways of dopamine and dopamine agonists in prolactinomas. Front. Endocrinol. 9, 768 (2019).
Shaikhpoor, M., Ahangari, G., Sadeghizadeh, M., Khosravi, A. & Derakhshani Deilami, G. Significant changes in D2-like dopamine gene receptors expression associated with non-small-cell lung cancer: could it be of potential use in the design of future therapeutic strategies?. Curr. Cancer Ther. Rev. 8, 304–310 (2012).
Google Scholar
Sheikhpour, M., Ahangari, G., Sadeghizadeh, M. & Deezagi, A. A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: a new approach for the treatment of human non-small cell lung cancer. Int. J. Immunopathol. Pharmacol. 26, 393–402 (2013).
Google Scholar
Sheikhpour, M. et al. Co-administration of curcumin and bromocriptine nano-liposomes for induction of apoptosis in lung cancer cells. Iran. Biomed. J. 24, 24 (2020).
Google Scholar
Sheikhpour, M., Barani, L. & Kasaeian, A. Biomimetics in drug delivery systems: A critical review. J. Control. Release 253, 97–109 (2017).
Google Scholar
Sheikhpour, M., Golbabaie, A. & Kasaeian, A. Carbon nanotubes: a review of novel strategies for cancer diagnosis and treatment. Mater. Sci. Eng. C 76, 1289–1304 (2017).
Google Scholar
Hao, H., Chen, Y. & Wu, M. Biomimetic nanomedicine toward personalized disease theranostics. Nano Res. 14, 2491–2511. https://doi.org/10.1007/s12274-020-3265-z (2021).
Google Scholar
Li, Z. et al. The toxicity of hydroxylated and carboxylated multi-walled carbon nanotubes to human endothelial cells was not exacerbated by ER stress inducer. Chin. Chem. Lett. 30, 582–586. https://doi.org/10.1016/j.cclet.2018.12.011 (2019).
Google Scholar
Yang, Q. et al. Pre-incubated with BSA-complexed free fatty acids alters ER stress/autophagic gene expression by carboxylated multi-walled carbon nanotube exposure in THP-1 macrophages. Chin. Chem. Lett. 30, 1224–1228 (2019).
Google Scholar
Zomorodbakhsh, S., Abbasian, Y., Naghinejad, M. & Sheikhpour, M. The effects study of isoniazid conjugated multi-wall carbon nanotubes nanofluid on Mycobacterium tuberculosis. Int. J. Nanomed. 15, 5901–5909. https://doi.org/10.2147/IJN.S251524 (2020).
Google Scholar
Stockert, J. C., Blázquez-Castro, A., Cañete, M., Horobin, R. W. & Villanueva, A. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. Acta Histochem. 114, 785–796. https://doi.org/10.1016/j.acthis.2012.01.006 (2012).
Google Scholar
Babaei, H. et al. Increased circulation mobilization of endothelial progenitor cells in preterm infants with retinopathy of prematurity. J. Cell. Biochem. 119, 6575–6583 (2018).
Google Scholar
Siavashi, V., Nassiri, S. M., Rahbarghazi, R., Vafaei, R. & Sariri, R. ECM-dependence of endothelial progenitor cell features. J. Cell. Biochem. 117, 1934–1946 (2016).
Google Scholar
Brzeziński, M. & Biela, T. Polylactide nanocomposites with functionalized carbon nanotubes and their stereocomplexes: A focused review. Mater. Lett. 121, 244–250 (2014).
Jiang, H., Zhao, P. J., Su, D., Feng, J. & Ma, S. L. Paris saponin I induces apoptosis via increasing the Bax/Bcl-2 ratio and caspase-3 expression in gefitinib-resistant non-small cell lung cancer in vitro and in vivo. Mol. Med. Rep. 9, 2265–2272 (2014).
Google Scholar
Mu, Q., Broughton, D. L. & Yan, B. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett. 9, 4370–4375 (2009).
Google Scholar
Öner, D. et al. Differences in MWCNT-and SWCNT-induced DNA methylation alterations in association with the nuclear deposition. Part. Fibre Toxicol. 15, 1–19 (2018).
Hoeppner, L. H. et al. Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells. Mol. Oncol. 9, 270–281 (2015).
Google Scholar
Kendall, R. T., Rivera‐Odife, E., Everett, P. B. & Senogles, S. E. (Wiley Online Library, 2006).
Basu, S. & Dasgupta, P. S. Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102, 113–124 (2000).
Google Scholar
Zhang, X., Liu, Q., Liao, Q. & Zhao, Y. Potential roles of peripheral dopamine in tumor immunity. J. Cancer 8, 2966 (2017).
Google Scholar
Roney, M. S. I. & Park, S.-K. Antipsychotic dopamine receptor antagonists, cancer, and cancer stem cells. Arch. Pharmacal. Res. 41, 384–408 (2018).
Google Scholar
Borcherding, D. C. et al. Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene 35, 3103–3113 (2016).
Google Scholar
Roy, S. et al. Activation of D2 dopamine receptors in CD133+ ve cancer stem cells in non-small cell lung carcinoma inhibits proliferation, clonogenic ability, and invasiveness of these cells. J. Biol. Chem. 292, 435–445 (2017).
Google Scholar
Campa, D. et al. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer. Lung Cancer 56, 17–23 (2007).
Google Scholar
Wu, X.-Y. et al. Overexpressed D2 dopamine receptor inhibits non-small cell lung cancer progression through inhibiting NF-κB signaling pathway. Cell. Physiol. Biochem. 48, 2258–2272 (2018).
Google Scholar
Esposito, E. et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25, 1521–1530 (2008).
Google Scholar
Seo, E.-J., Sugimoto, Y., Greten, H. J. & Efferth, T. Repurposing of bromocriptine for cancer therapy. Front. Pharmacol. 9, 1030 (2018).
Google Scholar
Li, Q. et al. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine. Mol. Cell. Endocrinol. 382, 377–384 (2014).
Google Scholar
Yan, H. et al. Toxicity of carbon nanotubes as anti-tumor drug carriers. Int. J. Nanomed. 14, 10179 (2019).
Google Scholar
Rastogi, V. et al. Carbon nanotubes: an emerging drug carrier for targeting cancer cells. J. Drug Deliv. 20, 14 (2014).
Xin, Y., Yin, M., Zhao, L., Meng, F. & Luo, L. Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer Biol. Med. 14, 228 (2017).
Google Scholar
Tran, S., DeGiovanni, P.-J., Piel, B. & Rai, P. Cancer nanomedicine: a review of recent success in drug delivery. Clin. Transl. Med. 6, 1–21 (2017).
AbouAitah, K. et al. Targeted nano-drug delivery of colchicine against colon cancer cells by means of mesoporous silica nanoparticles. Cancers 12, 144 (2020).
Google Scholar
Santos, T. et al. Sequential administration of carbon nanotubes and near-infrared radiation for the treatment of gliomas. Front. Oncol. 4, 180 (2014).
Google Scholar
Wang, L. et al. Synergistic anticancer effect of RNAi and photothermal therapy mediated by functionalized single-walled carbon nanotubes. Biomaterials 34, 262–274 (2013).
Google Scholar
Sheikhpour, M., Ahangari, G. & Sadeghizadeh, M. (AACR, 2013).
Jiang, Y. et al. Modulation of apoptotic pathways of macrophages by surface-functionalized multi-walled carbon nanotubes. PLoS One 8, e65756 (2013).
Google Scholar
Sato, Y. et al. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol. BioSyst. 1, 176–182 (2005).
Google Scholar
Singh, R. et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc. Natl. Acad. Sci. 103, 3357–3362 (2006).
Google Scholar
Rajarajeswari, M., Iyakutti, K., Lakshmi, I., Rajeswarapalanichamy, R. & Kawazoe, Y. Functionalized single-walled carbon nanotube (5, 0) as a carrier for isoniazid—A tuberculosis drug. Int. J. Comput. Mater. Sci. Eng. 4, 1550014 (2015).
Google Scholar
Attia, M. F., Anton, N., Wallyn, J., Omran, Z. & Vandamme, T. F. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J. Pharm. Pharmacol. 71, 1185–1198 (2019).
Google Scholar
